Gennex Laboratories Limited
GENNEX.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.33B
Close$
Share Statistics
| Market cap | $2.33 Billion |
|---|---|
| Enterprise Value | $2.33 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.76 |
| Beta | 0.99 |
| Outstanding Shares | 242,948,000 |
Return
| Return on Equity | 8.02% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 12.32 |
|---|---|
| PEG | -176.58 |
| Price to Sales | 1.37 |
| Price to Book Ratio | 1.07 |
| Enterprise Value to Revenue | 1.28 |
| Enterprise Value to EBIT | 9.86 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Gennex Laboratories Limited
125 employees
CEO: Arihant Baid Gennex Laboratories Limited specializes in the manufacturing of active pharmaceutical ingredients (bulk drugs), intermediate compounds, and biotechnological products. The company boasts a significant international presence, conducting bu...